Mechanism of action and potential therapeutic targets of ferroptosis suppressor protein 1 in liver diseases
- VernacularTitle:铁死亡抑制蛋白1在肝脏疾病中的作用机制及潜在治疗靶点
- Author:
Sisi WANG
1
;
Yaru WANG
1
;
Rui LIU
1
;
Jie QIN
1
Author Information
- Publication Type:Review
- Keywords: Liver Diseases; Arrestins; Ferroptosis
- From: Journal of Clinical Hepatology 2024;40(7):1493-1497
- CountryChina
- Language:Chinese
- Abstract: Ferroptosis suppressor protein 1 （FSP1） is another major ferroptosis regulator besides glutathione peroxidase 4， which can scavenge intracellular reactive oxygen species and lipid peroxides and inhibit ferroptosis. In view of the key role of the liver in iron and lipid metabolism and its susceptibility to oxidative damage， more and more evidence has shown that FSP1 plays an important role in liver diseases such as metabolic associated fatty liver disease， hepatocellular carcinoma， acute liver failure， and alcoholic liver disease， and the related targets of FSP1 are expected to become a potential treatment option. This article comprehensively reviews FSP1， with a focus on the role of FSP1 in the pathophysiology of several common liver diseases and the potential of FSP1 as a target of liver diseases， in order to provide new ideas for the treatment of liver diseases.
